CHINO HILLS, CALIFORNIA / ACCESS Newswire / November 4, 2025 / SOHM, Inc. (OTCID:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, a leader in ...

In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...

Dr. Katz's research shows how important it is for all breast cancer survivors to have access to genetic testing services, ...

The Cyclin A2 gene (CCNA2), which turns off after birth in humans, can promote cardiac repair in adult human cardiomyocytes.

Scientists are exploring leading-edge technologies that could transform how cancer is studied, detected and treated by catching it earlier, when it's more treatable and survival rates are highest.

Researchers have gained new insights into the genetic basis of rye reproduction. They have demonstrated how plants recombine ...

Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...

Thematic indexing is Among the fastest-growing segments in the ETF market. At Bloomberg’s ETFs in Depth event in London, ...

How they’re doing it: The new company, called Preventive, is being formed to research so-called “heritable genome editing,” ...